THERMO FISHER SCIENTIFIC INC. 8-K

What Happened Thermo Fisher Scientific Inc. filed an 8-K (May 26, 2026) reporting the voting results from its annual meeting held May 20, 2026. All 11 director nominees were elected for one‑year terms expiring at the 2027 annual meeting. The non‑binding, advisory "say‑on‑pay" proposal on executive compensation was not approved. PricewaterhouseCoopers LLP was ratified as the Company’s independent registered public accounting firm for fiscal year 2026.

Key Details

• 11 directors elected (one‑year terms). Selected vote counts for nominees:
  • Marc N. Casper: 294,015,478 For; 20,501,640 Against; 1,202,257 Abstain
  • Debora L. Spar: 314,426,121 For; 311,821 Against; 981,433 Abstain
  • Dion J. Weisler: 281,791,656 For; 32,960,105 Against; 967,614 Abstain
• Advisory vote on named executive officer compensation (say‑on‑pay): For 99,928,178; Against 214,525,673; Abstain 1,265,524 — the proposal was not approved.
• Ratification of independent auditor (PricewaterhouseCoopers LLP): For 296,866,709; Against 36,064,900; Abstain 999,237.

Why It Matters The company reported formal shareholder approval of its Board slate and auditor, which confirms corporate governance continuity for the coming year. The failure of the non‑binding say‑on‑pay vote indicates a clear majority of shares voted against the company’s executive compensation disclosure/plan at the meeting; because the vote is advisory, it does not automatically change pay arrangements but is a direct shareholder signal documented in this 8‑K.